G1 Therapeutics to Participate in Two August Investor Conferences

Rhea-AI Summary

G1 Therapeutics, Inc. (Nasdaq: GTHX) to participate in 2023 BTIG Virtual Biotechnology Conference on August 7, and 2023 Wedbush PacGrow Healthcare Conference on August 9. CEO Jack Bailey and team will engage in investor meetings. BTIG events are for prospective and existing clients only. Contact respective representatives for participation.

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that it will participate in two August investor conferences.

• On Monday August 7, 2023, G1’s Chief Executive Officer Jack Bailey and other members of G1’s Executive Team will participate in the 2023 BTIG Virtual Biotechnology Conference. BTIG-hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative.
  
  
• On Wednesday August 9, 2023, the G1 team will also participate in one-on-one meetings with institutional investors during the 2023 Wedbush PacGrow Healthcare Conference in New York City. If interested in a meeting, please contact your Wedbush PacGrow representative.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1 has a deep clinical pipeline and is executing a development plan evaluating trilaciclib in a variety of solid tumors, including breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc

Contacts:
Will Roberts
Communications Officer
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

 

FAQ

What conferences will G1 Therapeutics participate in August 2023?

G1 Therapeutics will participate in the 2023 BTIG Virtual Biotechnology Conference on August 7 and the 2023 Wedbush PacGrow Healthcare Conference on August 9.

Who will represent G1 Therapeutics at the conferences?

G1's CEO Jack Bailey and other members of the Executive Team will participate in the BTIG Virtual Biotechnology Conference, and the G1 team will engage in one-on-one meetings with institutional investors at the Wedbush PacGrow Healthcare Conference.

Are the BTIG events open to the public?

No, BTIG-hosted events are intended for prospective and existing BTIG clients only.

How can one participate in the live event?

To listen to the live event at the BTIG Virtual Biotechnology Conference, interested parties should contact their BTIG representative.

How can institutional investors arrange a meeting with G1 Therapeutics at the Wedbush PacGrow Healthcare Conference?

Institutional investors interested in a meeting with G1 at the Wedbush PacGrow Healthcare Conference should contact their Wedbush PacGrow representative.